Blickenstaff KIM D
SEC-identified person · CIK 1238913 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Panacea Acquisition Corp PANA | Director | filed 2021–2026 |
| Tandem Diabetes Care INC TNDM | Director · PRESIDENT AND CEO | filed 2013–2024 |
| Opy Acquisition Corp. I OHAA | Director | filed 2021–2021 |
| Medivation, INC. MDVN.OB | Director | filed 2007–2016 |
| Senorx INC SENO | Director | filed 2007–2010 |
| Biosite INC BSTE | Chairman & CEO | filed 2007–2007 |
| Dexcom INC DXCM | Director | filed 2006–2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.